MBX — Microbix Biosystems Cashflow Statement
0.000.00%
Last trade - 00:00- CA$46.03m
- CA$39.88m
- CA$16.51m
- 73
- 52
- 68
- 69
Annual cashflow statement for Microbix Biosystems, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.032 | -6.23 | 3.23 | 1.79 | -0.039 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.361 | 3.52 | 1.27 | 0.98 | -1.99 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.929 | 0.461 | -3.22 | -0.34 | -0.22 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 0.044 | 0.009 | 2.11 | 3.47 | -1.09 |
| Capital Expenditures | -0.515 | -0.814 | -1.24 | -2.03 | -1.02 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 0.621 | 0 | — |
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.515 | -0.814 | -0.622 | -2.03 | -1.02 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.522 | 0.802 | 8.41 | 2.06 | 0.229 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.051 | -0.003 | 9.89 | 3.5 | -1.88 |